280
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Chitosan oligosaccharide as prospective cross-linking agent for naproxen-loaded Ca-alginate microparticles with improved pH sensitivity

, , , , &
Pages 77-88 | Received 05 Oct 2011, Accepted 13 Jan 2012, Published online: 18 Feb 2012

References

  • Fernandez-Hervas MJ, Holgado MA, Fini A, Fell JT. (1998.) In vitro evaluation of alginate beads of a diclofenac salt. Int J Pharm, 163:23–34.
  • Simsek-Ege FA, Bond GM, Stringer J. (2003). Polyelectrolyte complex formation between alginate and chitosan as a function of pH. J Appl Polym Sci, 88:346–351.
  • Martinsen A, Skjåk-Braek G, Smidsrød O. (1989). Alginate as immobilization material: I. Correlation between chemical and physical properties of alginate gel beads. Biotechnol Bioeng, 33:79–89.
  • Tønnesen HH, Karlsen J. (2002). Alginate in drug delivery systems. Drug Dev Ind Pharm, 28:621–630.
  • George M, Abraham TE. (2006). Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan–a review. J Control Release, 114:1–14.
  • Polk A, Amsden B, De Yao K, Peng T, Goosen MF. (1994). Controlled release of albumin from chitosan-alginate microcapsules. J Pharm Sci, 83:178–185.
  • Huguet ML, Dellacherie E. (1996). Calcium alginate beads coated with chitosan: effect of the structure of encapsulated materials on their release. Process Biochem, 31:745–751.
  • Wang FQ, Li P, Zhang JP, Wang AQ, Wei Q. (2010). A novel pH-sensitive magnetic alginate-chitosan beads for albendazole delivery. Drug Dev Ind Pharm, 36:867–877.
  • Calija B, Cekic N, Savic S, Krajišnik D, Daniels R, Milic J. (2011). An investigation of formulation factors affecting feasibility of alginate-chitosan microparticles for oral delivery of naproxen. Arch Pharm Res, 34:919–929.
  • Yu CY, Zhang XC, Zhou FZ, Zhang XZ, Cheng SX, Zhuo RX. (2008). Sustained release of antineoplastic drugs from chitosan-reinforced alginate microparticle drug delivery systems. Int J Pharm, 357:15–21.
  • Cekic ND, Milic JR, Savic SD, Savic MM, Jovic Z, Daniels R. (2009). Influence of the preparation procedure and chitosan type on physicochemical properties and release behavior of alginate-chitosan microparticles. Drug Dev Ind Pharm, 35:1092–1102.
  • Jeon YJ, Shahidi F, Kim SK. (2000). Preparation of chitin and chitosan oligomers and their applications in physiological functional foods. Food Rev Int, 61:159–176.
  • Chae SY, Son S, Lee M, Jang MK, Nah JW. (2005). Deoxycholic acid-conjugated chitosan oligosaccharide nanoparticles for efficient gene carrier. J Control Release, 109:330–344.
  • Eskilson C. (1985). Controlled release by microencapsulation. Manuf Chem, 563:33–39.
  • Kramer J, Blume H. 1994. Biopharmaceutical aspects of multiparticulates. In: Ghebre-Sellasie Y, ed. Multiparticulate Oral Drug Delivery. New York: Marcel Dekker, 307–332.
  • Iruín A, Fernández-Arévalo M, Alvarez-Fuéntes J, Fini A, Holgado MA. (2005). Elaboration and “in vitro” characterization of 5-ASA beads. Drug Dev Ind Pharm, 31:231–239.
  • Maghsoodi M. (2009). Physicomechanical properties of naproxen-loaded microparticles prepared from Eudragit l100. AAPS PharmSciTech, 10:120–128.
  • Liu HJ, Li P, Wei Q. (2010). Magnetic N-succinyl chitosan/alginate beads for carbamazepine delivery. Drug Dev Ind Pharm, 36:1286–1294.
  • Smrdel P, Bogataj M, Mrhar A. (2008). The influence of selected parameters on the size and shape of alginate beads prepared by ionotropic gelation. Sci Pharm, 76:77–89.
  • Kittur FS, HarishPrashanth KV, Sankar KU, Tharanathan RN. (2002). Characterization of chitin, chitosan and their carboxymethyl derivatives by differential scanning calorimetry. Carbohyd Polym, 49:185–193.
  • Mura P, Faucci MT, Maestrelli F, Furlanetto S, Pinzauti S. (2002). Characterization of physicochemical properties of naproxen systems with amorphous β-cyclodextrin-epichlorohydrin polymers. J Pharm Biomed Anal, 29:1015–1024.
  • Sartori C, Finch DS, Ralph B, Gilding K. (1997). Determination of the cation content of alginate thin films by FTi.r. spectroscopy. Polymer, 38:43–51.
  • Lawrie G, Keen I, Drew B, Chandler-Temple A, Rintoul L, Fredericks P et al. (2007). Interactions between alginate and chitosan biopolymers characterized using FTIR and XPS. Biomacromolecules, 8:2533–2541.
  • Sarmento B, Martins S, Ribeiro A, Veiga F, Neufeld R, Ferreira D. (2006). Development and comparison of different nanoparticulate polyelectrolyte complexes as insulin carriers. Int J Pept Res Ther, 12:131–138.
  • Brugnerotto J, Lizardi J, Goycoolea FM, Argiielles MW, Desbrieres J, Rinaudo M. (2001). An infrared investigation in relation with chitin and chitosan characterization. Polymer, 42:3569–3580.
  • Junco S, Casimiro T, Ribeiro N, Nunes Da Ponte M, Cabralmarques H. (2002). A comparative study of naproxen – β cyclodextrin complexes prepared by conventional methods and using supercritical carbon dioxide. J Incl Pheno Macro, 44:117–121.
  • Carriazo D, Del Arco M, Martín C, Ramos C, Rives V. (2010). Influence of the inorganic matrix nature on the sustained release of naproxen. Micropor Mesopor Mat, 130:229–238.
  • Ferreira Almeida P, Almeida AJ. (2004). Cross-linked alginate-gelatine beads: a new matrix for controlled release of pindolol. J Control Release, 97:431–439.
  • Gåserød O, Smidsrød O, Skjåk-Braek G. (1998). Microcapsules of alginate-chitosan–I. A quantitative study of the interaction between alginate and chitosan. Biomaterials, 19:1815–1825.
  • Dainty AL, Goulding KH, Robinson PK, Simpkins I, Trevan MD. (1986). Stability of alginate-immobilized algal cells. Biotechnol Bioeng, 28:210–216.
  • Liu LS, Liu SQ, Steven, YN, Froix M, Ohno T, Heller J. (1997). Controlled release of interleukin-2 for tumour immunotherapy using alginate/chitosan porous microspheres. J Control Release, 43: 65–74.
  • Mayur G, Sankalia M, Mashru R, Sankali J, Sutariya V. (2007). Reversed chitosan–alginate polyelectrolyte complex for stability improvement of alpha-amylase: optimization and physicochemical characterization. Eur J Pharm Biopharm, 65:215–232.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.